- Home
- GIPR vs KZIA Comparison
GIPR vs KZIA Comparison
Compare GIPR & KZIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GIPR
- KZIA
- Stock Information
- Founded
- GIPR 2015
- KZIA 1994
- Country
- GIPR United States
- KZIA Australia
- Employees
- GIPR N/A
- KZIA N/A
- Industry
- GIPR Real Estate Investment Trusts
- KZIA Biotechnology: Pharmaceutical Preparations
- Sector
- GIPR Real Estate
- KZIA Health Care
- Exchange
- GIPR Nasdaq
- KZIA Nasdaq
- Market Cap
- GIPR 13.8M
- KZIA 12.6M
- IPO Year
- GIPR 2021
- KZIA 1999
- Fundamental
- Price
- GIPR $2.04
- KZIA $0.42
- Analyst Decision
- GIPR Hold
- KZIA Strong Buy
- Analyst Count
- GIPR 1
- KZIA 1
- Target Price
- GIPR N/A
- KZIA $2.00
- AVG Volume (30 Days)
- GIPR 27.9K
- KZIA 1.7M
- Earning Date
- GIPR 11-12-2024
- KZIA 10-15-2024
- Dividend Yield
- GIPR 23.17%
- KZIA N/A
- EPS Growth
- GIPR N/A
- KZIA N/A
- EPS
- GIPR N/A
- KZIA N/A
- Revenue
- GIPR $9,659,091.00
- KZIA $382.00
- Revenue This Year
- GIPR N/A
- KZIA $4,053,954.00
- Revenue Next Year
- GIPR N/A
- KZIA N/A
- P/E Ratio
- GIPR N/A
- KZIA N/A
- Revenue Growth
- GIPR 74.44
- KZIA N/A
- 52 Week Low
- GIPR $1.93
- KZIA $0.19
- 52 Week High
- GIPR $4.64
- KZIA $1.58
- Technical
- Relative Strength Index (RSI)
- GIPR 36.49
- KZIA 56.50
- Support Level
- GIPR $2.13
- KZIA $0.38
- Resistance Level
- GIPR $2.10
- KZIA $0.46
- Average True Range (ATR)
- GIPR 0.11
- KZIA 0.04
- MACD
- GIPR -0.00
- KZIA 0.01
- Stochastic Oscillator
- GIPR 11.11
- KZIA 52.70
About GIPR Generation Income Properties Inc.
Generation Income Properties Inc is an internally managed real estate investment company focused on acquiring and managing income-producing retail, office and industrial properties net leased to high-quality tenants in major markets throughout the United States. Its key source of revenue is the rental income. The company holds properties in Alabama, Arizona, Colorado, the District of Columbia, Florida, Illinois, North Carolina and Virginia.
About KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing innovative anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors.